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a  b  s  t  r  a  c  t
Propofol  is  an  ultra-short  acting  anesthetic  agent.  The  information  on the  pharmacological
and  toxicological  effects  of propofol  in the  chicken  is rather  limited.  This  study  examines  the
toxicity and  pharmaco-behavioral  effects  of  propofol  given  intraperitoneally  in  7–10 day-
old chicks.  The  median  effective  doses  of propofol  for  the induction  of sedation,  analgesia
to  electric  stimulation  and  sleep  in the chicks  were  1.82,  2.21  and  5.71 mg/kg,  respectively.
The  24-h  median  lethal  dose  of propofol  in  chicks  was  57.22  mg/kg.  The  therapeutic  indices
of  propofol  for  sedation,  analgesia  and  sleep  were  31.4,  25.9  and  10,  respectively.  Propo-
fol  at  0.5 and  1 mg/kg  reduced  the  locomotor  activity  and  increased  the  duration  of  tonic
immobility  in  chicks.  Propofol  at 2 and  4 mg/kg  caused  analgesia  to electric  stimulation  as
well  as  analgesia  and anti-inﬂammatory  responses  against  formalin  test  in chicks.  Propofol
at 5,  10  and  20  mg/kg  induced  sleep  in  chicks  for 8.4 to  25  min.  Physostigmine  shortened  the
sleep  duration  of propofol.  Data  suggest  that  propofol  induces  anti-inﬂammatory  action  andChemical compounds studied in this article:
Formalin (PubChem CID: 712)
Physostigmine (PubChem CID: 5983)
Propofol (PubChem CID: 4943)
central nervous  system  depression  in chicks  resulting  in sedation,  analgesia  and anesthesia
with wide  safety  margin.  These  effects  could  form  the basis  of  further  pharmacological  and
toxicological  studies  on  propofol  in  the  young  chick  model,  and the  drug  could  be safely
applied  clinically  in  the  chicken.
rs.  Publ
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1. Introduction
Propofol, 2,6-diisopropylphenol, is an ultra-short act-
ing  anesthetic agent used intravenously in humans [1,2]
and  animals [3,4]. It is a non-narcotic and non-barbiturate
anesthetic agent which is usually administered for main-
tenance of anesthesia with rapid induction and recovery
phases [1]. Propofol has been shown to be increasingly
used in veterinary practice [4], especially in dogs and cats
[5].  Several studies have attempted to apply propofol as an
anesthetic  in birds such as wild turkeys [6], barn owl  [7],
free  ranging wood ducks [8], mallard ducks [9], pigeons
[10],  ostriches [11] and Amazon parrots [12] with varying
dosages and resultant effects. These studies reported that
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general effects of propofol in birds were anesthesia of short
duration  of action, good muscle relaxation with minimal
cardiovascular and respiratory adverse effects.
Other than the anesthetic effects of propofol which are
well  known, several studies have shown that the drug
may  induce various pharmacological effects not related
to  general anesthesia [13]. These include in vitro and
in  vivo antioxidant actions [14,15], treatment of erectile
dysfunction [16], as well as sedative [17], anxiolytic [18],
analgesic [2], antiemetic[2], immunomodulatory [19] and
neuromodulatory effects [20]. There is no speciﬁc phar-
macological antagonist of propofol. However, studies have
shown  that physostigmine enhances recovery from propo-
fol  anesthesia in humans [21,22]. This effect could be
related to the central stimulatory action of physostigmine
which inhibits acetylcholinesterase activity as found in
case  of isoﬂurane-induced anesthesia in horses [23].
Based on the studies of propofol effects in avian species
[8,11,12] it appears that the potential chick model of
is is an open access article under the CC BY-NC-ND license
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ropofol effects would be an addition to the already exist-
ng  animal models for examining the pharmacological
nd toxicological effects of general anesthetics [13,24].
europharmacological effects are vital issues to be taken
nto  consideration in any study involving animal mod-
ls  used to examine anesthetic and non-anesthetic effects
f  general anesthetics [25]. Despite the reported central
ervous system (CNS) depressant effects of propofol in
he  avian species [6–12], the information on the phar-
acological and toxicological actions of propofol in the
hicken  from behavioral point of view is rather scarce
4,26]. One study reported the cardiopulmonary effects
f  propofol anesthesia in adult chickens preanesthetized
ith isoﬂurane [27]. More recently we reported an isobolo-
raphic  analysis of combined sedative and hypnotic uses
f  propofol with the dissociative anesthetic ketamine and
he  sedative analgesic xylazine in chicks [28]. Therefore,
he present study explores the toxicity and pharmaco-
ehavioral effects of propofol in 7–10 day-old chicks.
peciﬁcally, the aim of the present study lies in two cat-
gories. First, we attempted to characterize and examine
on-anesthetic and potential therapeutic actions (seda-
ion,  analgesia, anti-inﬂammation, hypoactivity and sleep)
f  propofol which would be an added information in the
vian  practice and the chick model of examining subanes-
hetic effects of the drug. Second, we examined the acute
oxicity of propofol to set a benchmark of toxic response
nd the drug margin of safety in chicks and whether the
entral  depressant effect can be antagonized by the acetyl-
holinesterase inhibitor physostigmine.
. Materials and methods
.1.  Animals
Day old Ross broiler chicks of both sexes were purchased
rom a certiﬁed local hatchery and they were maintained
ntil the age of 7–10 days when the experiments were
one. The chicks were housed in a room with a temperature
f  32–35 ◦C, constant lighting, and wood shavings as ﬂoor
itter,  with free access to drinking water and feed. The com-
ercial  injectable solution of propofol (10 mg/ml, Astra,
eneca, UK) was further diluted in distilled water to obtain
he  concentrations needed for injection intraperitoneally
i.p.) in a volume of 10 ml/kg body weight. Chicks in control
roups  were injected i.p. with physiological saline solution
t  10 ml/kg. All drug solutions were freshly prepared before
ach  experiment. The Graduate Studies Committee of the
ollege  of Veterinary Medicine at the University of Mosul
eviewed and approved the present study. All experiments
omplied with our institutional regulations addressing ani-
al  use, attention and humane care which are based on the
uidelines  of the National Research Council [29].
.2. Determination of the median effective doses (ED50s)
f  propofol for the induction of sedation, analgesia and
nesthesia in chicksThe  up-and-down method [30] was used to deter-
ine separately the individual ED50s of propofol for the
nduction of sedation, analgesia and anesthesia in chicks.gy Reports 1 (2014) 562–568 563
The  criteria for the occurrence of sedation in chicks were
drooping of the head, closed eyelids, reduced motility or
immotility, decreased distress calls, or recumbency [31,32].
Analgesia was  assessed by the increase in pain threshold
using an electric stimulator (SRI, Scientiﬁc and Research
Instruments Ltd, UK) after setting the frequency at 50 Hz,
the  width at 5 ms  and the pulse amplitude at 10 volts. The
electrodes of the stimulator were gently inserted subcu-
taneously at an upper chest region, wetted with distilled
water, under the wing. The response of the chick to pain
after  electric stimulation was in the form of distress calls
and/or resisting with wing ﬂapping [33]. Each chick was
subjected to a minimum voltage that caused aversive pain
response  before the propofol injection and then 15 min
after  the injection. The increase or decrease in voltage
that caused pain response was calculated for each group.
Usually, the latency for positive analgesic response was
apparent within 2 s after the electrical stimulation. The
onset  of anesthesia (sleep) was  manifested as loss of right-
ing  reﬂex when the chick was  gently placed on one side
[34,35]. We  monitored each chick within 20 min  after the
injection  of propofol for the induction of sedation, analgesia
or  anesthesia. The initial dose of propofol was  at 2 mg/kg for
the  induction of sedation and analgesia and it was  5 mg/kg
for  the induction of anesthesia. The choice of these doses
based  on preliminary experiments in chicks. The experi-
ments were concluded using only 5 or 6 chicks/experiment
within 5–6 days.
2.3.  Determination of the median lethal dose (LD50) of
propofol in chicks
We  determined the acute (24-h) LD50 of propofol in
chicks by the up-and-down method [30]. This experiment
was done so that the relative pharmacological effects and
behavioral outcome at the doses used could be compared
to  a standard benchmark of acute toxicity. The dosages of
propofol  ranged between 40 and 100 mg/kg with an initial
dose  at 100 mg/kg. The chicks were individually observed
for  signs of toxicosis for 1 h after the drug injection, and
then  we  recorded the 24-h lethality. This experiment was
concluded using only 6 chicks within 6 days.
2.4. Behavioral effects of propofol
Twenty seven chicks were randomly divided into three
groups of nine birds each. The chicks were injected with
either  physiological saline solution (control) or with propo-
fol  at 0.5 and 1 mg/kg. These doses of propofol were below
the  ED50 of propofol for the induction of sedation and they
did  not produce overt signs of sedation in the chicks. The
3-min  open-ﬁeld activity of each chick was monitored 1 h
after  the propofol injection as described before [32]. The
dimensions of the open-ﬁeld box were 60 × 60 × 30 cm,
and  its arena was  divided into 16 equal squares with
50  g of wheat grains scattered evenly on the surface. After
the  open-ﬁeld activity test, each chick was  subjected to
tonic  immobility test which is considered a kind of fear
response in birds [34,36] and the duration of immobility
was recorded.
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2.5. Analgesic effect of propofol in chicks
Thirty two  chicks were randomly divided into four
groups of eight birds each. The chicks were injected with
either  physiological saline solution (control) or with propo-
fol  at 1, 2 and 4 mg/kg. The highest dose of propofol
was almost two-fold of the analgesic ED50 of the drug.
For  each chick, we measured the minimum voltage that
caused  aversive pain response, as mentioned in the previ-
ous  experiment, before propofol injection and then 15 min
after  the injection. The increase in the voltage in each
group was assessed statistically to determine the analgesic
response of the chicks to propofol.
Using another analgesic-anti-inﬂammatory protocol, 24
chicks  were randomly divided into three groups of eight
birds  each. Pain and inﬂammatory responses were induced
in  the chicks by injecting 0.05 ml  of 0.1% aqueous solu-
tion  of formalin into the planter region of the right foot
[37,38]. The planter of the left foot was injected with phys-
iological saline solution (0.05 ml)  as a control measure. The
chicks  were treated with either physiological saline solu-
tion  (control) or with propofol at 2 and 4 mg/kg 15 min
before the formalin injection. Immediately after the for-
malin  injection, we recorded within 3 min  the latency to lift
the  right foot and the frequency of lifting the right foot in
response  to formalin injection. Further, we determined the
anti-inﬂammatory effect of propofol by measuring the foot
thickness  (mm)  with an electronic digital caliber (Electron-
ics  Lab, China) before and 1 h after the formalin injection.
The anti-inﬂammatory response (%) was calculated as fol-
lows:
% anti-inﬂammatory response =
[
change in foot thickne
c
×100
2.6. Propofol-induced sleep in chicks
Twenty seven chicks were randomly divided into three
groups of nine birds each. The chicks were injected with
propofol at 5, 10 or 20 mg/kg. The latency to onset of loss
of  righting reﬂex (sleep) and its duration after the propofol
injection were recorded for each chick [34,39]. The sleep
time  was estimated from the time of loss of the righting
reﬂex when the chick was placed on one side or from the
Table 1
Median effective doses (ED50) of propofol injected intraperitoneally for induction
Variable Sedation 
ED50 (mg/kg) 1.82 
Range  of the doses used (mg/kg) 2.0 − 1.75 = 0.25 
Initial dose (mg/kg) 2 
Last  dose (mg/kg) 2 
Number  of chicks used 5 (XOXOX)a
Increase or decrease in the dose (mg/kg) 0.25 
Latency  in min to onset (minimum–maximum) 2–3 
Duration  in min  (minimum–maximum) 6–7 
Minimum–maximum voltage that caused pain NA 
a X, positive response (sedation, analgesia or sleep); O, no response. NA, no
up-and-down method [30].gy Reports 1 (2014) 562–568
ntrol group-change in foot thickness of propofol group
 in foot thickness of control group
]
time  of sternal recumbency with closed eyelids to the time
of  standing unaided.
2.7.  Antagonism of propofol sleep in chicks by
physostigmine
Thirty six chicks were randomly divided into four
groups of nine birds each. The chicks were injected with
propofol at 20 mg/kg. Immediately, after the propofol
injection the chicks were treated intramuscularly (i.m.)
with  physostigmine (Fluka, Switzerland) at 0.05, 0.1 or
0.2  mg/kg. The doses of physostigmine were obtained from
literature [40,41] and they were prepared in physiological
saline solution with a volume of administration at 5 ml/kg.
The  duration of loss of righting reﬂex was recorded for
each  chick and the lethality in each treatment group was
recorded 24 h after the propofol injection.
2.8. Statistics
We  used the Past Statistics Package (http://folk.uio.no/
ohammer/past/index.html) to statistically analyze the
data. Parametric data as multiple means were analyzed
by one way analysis of variance followed by the least sig-
niﬁcant  difference test [42]. Non-parametric data were
subjected to Mann–Whitney-U-test [42], whereas fre-
quency data were analyzed by the Fisher’s exact probability
test  [43]. The accepted level of statistical signiﬁcance was
at  p < 0.05.
3. Results
The ED50 values of propofol for the induction of seda-
tion, analgesia and anesthesia (sleep) in the chicks were
1.82,  2.21 and 5.71 mg/kg, i.p., respectively (Table 1). Chicks
sedated  with propofol were docile, showed head drooping,
closed eyelids, immobility, reduced distress calls. The signs
of  sleep were characterized by recumbency and loss of the
righting  reﬂex. No death occurred during the ED50 exper-
iments. The acute (24-h) LD50 value of propofol in chicks
 of sedation, analgesia and sleep in 7–10 day-old chicks.
Analgesia Sleep
2.21 5.71
2.5 − 2.0 = 0.5 7 − 5 = 2
2 5
2.25 7
6 (OOXXOX)a 5 (XOOOX)a
0.25 1
ND 2–3
ND 6–9
9–13 before propofol 10–15 after propofol NA
t applicable; ND, not determined. The ED50s were determined by the
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Table 2
The  acute (24-h) median lethal dose (LD50) of propofol injected intraperi-
toneally in 7–10 day-old chicks and the calculated therapeutic indices for
sedation, analgesia and sleep.
Variable Result
LD50 (mg/kg) 57.22
Range of the doses used (mg/kg) 100 − 40 = 60
Initial  dose (mg/kg) 100
Last dose (mg/kg) 40
Number of chicks used 6 (XXOXXO)a
Increase or decrease in the dose (mg/kg) 20
latency to onset of poisoning
(minimum-maximum)
1–1.5
Therapeutic  index Sedation  = 31.4
Analgesia = 25.9
Sleep = 10.0
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Table 4
Analgesic effect of propofol injected intraperitoneally in chicks subjected
to electric stimulation.
Propofol (mg/kg) Increase or
decrease in voltage
causing  pain (V)†
% Chicks
showed
analgesia
0 (saline-control) −1.63 ± 0.42 0
1  −0.13 ± 0.52 25
2 1.75 ± 0.7* 75*
4 6.0 ± 0.71*ab 100*
† Values are mean ± SE of 8 chicks/group.
* Signiﬁcantly different from the respective control value, p < 0.05.
a,b Signiﬁcantly different from the respective value of the groups treated
T
E
V
t = death; O = survival. The LD50 was determined by the up-and-down
ethod [30]. Therapeutic index = LD50/ED50. The ED50 values were
btained from Table 1.
as 57.22 mg/kg, i.p. (Table 2). Signs of poisoning appeared
ithin  less than 2 min  in chicks, and they consisted of
ead  drooping, closed eyelids, ataxia, recumbency on the
ternum  and tachypnea before death. The calculated ther-
peutic  indices of propofol for the induction of sedation,
nalgesia and anesthesia in chicks were 31.4, 25.9 and 10,
espectively (Table 2).
The  3-min open-ﬁeld activities of chicks injected with a
ingle  dose of propofol at 0.5 or 1 mg/kg, i.p. are shown in
able  3. Generally, propofol dose-dependently reduced the
ocomotor  activity of the chicks 1 h after each treatment
s seen by a signiﬁcant increase in the latency to move
rom the center of the open-ﬁeld arena and decreases in
he  frequency of lines crossed and escape jumps in compar-
son  with the control values (Table 3). Propofol treatments
ecreased the percentages of chicks moved in the open ﬁeld
est  by 33 and 100%, respectively (Table 3). Propofol treat-
ents  also signiﬁcantly and dose-dependently prolonged
he  durations of tonic immobility of the chicks when com-
ared  with the control value (Table 3).
Propofol at 2 and 4 mg/kg, i.p. signiﬁcantly and dose-
ependently caused analgesia by increasing the voltage
eeded to elicit pain in chicks in comparison with the
ontrol group (Table 4). Concurrently, the percentages of
hicks  treated with propofol at 1, 2 and 4 mg/kg, which
howed analgesia were 25, 75 and 100%, respectively. Using
able 3
ffects of propofol on 3-min open-ﬁeld activity and tonic immobility test in chick
Variable Propofol (mg/kg, intrap
0 (Saline-control) 
Latency to move (seconds) 27.0 ± 2.4 
Lines crossed 15.4  ± 2.1
Escape jumps 1.7 ± 0.8 
Distress calls (scores) 2.8 ± 0.1 
Pecking (scores) 0.7 ± 0.2 
Defecations  1.2 ± 0.1 
% Chicks moved 100 
Duration of tonic immobility (s) 4.3 ± 0.9 
alues are mean ± SE of 9 chicks/group. Each chick was  subjected to open ﬁeld act
est.
* Signiﬁcantly different from the respective control value, p < 0.05.
a Signiﬁcantly different from the respective value of the group treated with prowith propofol at 1 and 2 mg/kg, respectively, p < 0.05.
a different analgesic and anti-inﬂammatory test, propofol
(2  and 4 mg/kg, i.p.) also dose-dependently induced anal-
gesia  against formalin injected into the planter region of
the  foot of the chick. This was  shown by the signiﬁcant
increase in the latency to lift the right foot as well as
by  the signiﬁcant decrease in the frequency of foot lift-
ing  when compared with control values (Table 5). The
anti-inﬂammatory response of propofol was shown by the
signiﬁcant  reduction in foot thickness compared to the
control  value, with 89% positive responses in the chicks
(Table 5).
Propofol at 5, 10 and 20 mg/kg, i.p. signiﬁcantly and
dose-dependently decreased the latency to onset of sleep
in  chicks (Table 6). The duration of sleep ranged between
8.4  and 25 min. The lowest dose of propofol (5 mg/kg)
induced only sternal recumbency in chicks (100%), whereas
the  other doses (10 and 20 mg/kg) induced loss of the
righting reﬂex in chicks by 44 and 100%, respectively
(Table 6). Propofol at 5 mg/kg induced sternal recumbency
with closed eyelids in chicks, whereas the other two  doses
caused  loss of the righting reﬂex when the chicks were
gently placed on one side.
Physostigmine  at 0.05, 0.1 and 0.2 mg/kg, i.m. signiﬁ-
cantly and dose-dependently shortened the sleep time of
the  propofol (20 mg/kg, i.p.)-treated chicks (Table 7). How-
ever,  physostigmine at 0.1 and 0.2 mg/kg, i.m. caused 78
and  100% lethality in the propofol treated chicks when
examined 24 h later. No death occurred at the lowest dose
of  physostigmine (0.05 mg/kg, i.p.).
s.
eritoneally)
0.5 1.0
76.3 ± 20.9* –
2.8 ± 1.1* 0 ± 0*
0.8 ± 0.4 0 ± 0*
1.2 ± 0.1* 0.7 ± 0.7*,a
0 ± 0 0 ± 0
0.1 ± 0.1* 0.9 ± 0.1a
67 0*,a
23.8 ± 3.5* 70.3 ± 17.4*,a
ivity test 1 h after the propofol injection, followed by the tonic immobility
pofol at 0.5 mg/kg, p < 0.05.
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Table  5
Analgesic and anti-inﬂammatory effects of propofol injected intraperitoneally in chicks subjected to intraplanter formalin test.
Propofol (mg/kg) Latency to lift right
foot  (s)
Frequency of right
foot  lifting (counts)
Increase in foot
thickness  (mm)
Anti-inﬂammatory
response (%)
0 (saline-control) 1.0 ± 0 30.3 ± 1.6 0.9 ± 0.2 0
2  1.6 ± 0.9* 23.4 ± 1.9* 0.1 ± 0.03* 89
4  3.4 ± 0.3*,a 17.9 ± 1.4*,a 0.1 ± 0.03* 89
Values are mean ± SE of 8 chicks/group.
* Signiﬁcantly different from the respective control value, p < 0.05.
a Signiﬁcantly different from the respective value of the group treated with propofol at 2 mg/kg, p < 0.05.
Table 6
Propofol-induced sleep in chicks.
Propofol (mg/kg,
intraperitoneally)
Latency to sleep onset (min) Sleep duration (min) Type of sleep % Sleep chicks
5 7.1 ± 0.3 8.4 ± 0.4 Sternal recumbency 100
10  4.3 ± 0.3* 9.9 ± 0.7* Loss of righting reﬂex 44*
20 2.3 ± 0.2*a 25.0 ± 1.5*,a Loss of righting reﬂex 100a
Values are mean ± SE of 9 chicks/group. The chicks were monitored for the induction of sleep when they lost the righting reﬂex after placing them on one
side  or when they became recumbent on the sternum with closed eyelids.
* Signiﬁcantly different from the respective value of the group treated with pro
a Signiﬁcantly different from the respective value of the group treated with pro
Table 7
Physostigmine reduction of propofol-induced sleep (loss of righting
reﬂex) in chicks.
Physostigmine (mg/kg) Sleep duration (min) % 24-h death
0 (Saline-control) 19.6 ± 0.6 0
0.05 15.0 ± 0.5* 0
0.1 8.6 ± 0.4*a 78*a
0.2 3.3 ± 0.3*ab 100*a
Values are mean ± SE of 9 chicks/group. Physostigmine was  injected intra-
muscularly immediately after the intraperitoneal injection of propofol
(20 mg/kg).* Signiﬁcantly different the respective control value, p < 0.05.
a,b Signiﬁcantly different from the respective values of groups treated with
physostigmine at 0.05 and 0.1 mg/kg, respectively, p < 0.05.
4. Discussion
Propofol as an ultra short acting hypnotic was reported
to  induce sedation, analgesia and anesthesia in humans
[2]  and various animals species [3,4] including the avian
species [6,8,10,12]. However, such effects have not been
reported collectively in the chicken [27,28]. In the present
study, we report and characterize propofol effects in young
chicks.  These effects included propofol sedation, analgesia
and  sleep quantitatively (ED50s with LD50s and therapeu-
tic  indices) as well dose response effects.
Depending on the signs seen in the propofol treated
chicks, we have demonstrated the central nervous depres-
sant  action of the drug in the birds. Signs of sedation
(drooping of the head, closed eyelids, immobility, or
reduced motility) and sleep (recumbency or loss of the
righting reﬂex) have been reported to occur in the avian
species subjected to treatment with sedatives, hypnotics or
anesthetics  [31,39,44,45]. Our results further support the
ﬁndings  of others using propofol as an ultra short acting
anesthetic agent in avian species [6,8,10,12,27,28]. Further-
more,  propofol was found to be safe in the chicks depending
on  the calculated therapeutic indices which were high
for  the induction of sedation, analgesia and anesthesia inpofol at 5 mg/kg, p < 0.05.
pofol at 10 mg/kg, p < 0.05.
chicks  (Table 1). The induction of these effects was smooth
in  chicks and the recovery was also smooth and unevent-
ful.  In adult chickens, propofol was  lethal when given three
times  the induction doses at 4.5–9.7 mg/kg, intravenously
[27]. Age differences and variations in response due to
dosage  and route of administration are expected to con-
tribute  to the toxicity of propofol in the chicken. However,
dosages vary according to animal species and the required
therapeutic effect [3,4].
Further  experiments we  conducted demonstrated the
dose-dependent effects of propofol and durations of action
in  producing sedation, analgesia and sleep in chicks
(Tables 3–6). Such ﬁndings could be the basis of fur-
ther clinical trials of propofol in this avian species. The
mechanism of analgesic and anesthetic actions of propo-
fol  has been suggested to be related to modulation of
the  inhibitory effect of gamma-aminobutyric acid through
GABAA and potentiation of the glycinergic neurotransmis-
sion in the central nervous system and the spinal cord
[13,46].
We  unequivocally demonstrated the analgesic effect of
propofol  by two  different experimental protocols (elec-
tric  stimulation and formalin test) suggesting the analgesic
property of the drug at dosages well below the anes-
thetic ones in chicks (2 and 4 vs. 10 and 20 mg/kg, i.p.).
In  addition, the present study shows for the ﬁrst time the
anti-inﬂammatory action of propofol in the chick model of
formalin  test (reducing the foot edema). However, accord-
ing  to our results, one important limitation of the use of
propofol  as an anti-inﬂammatory agent is that it could
possibly modify animal behavior at the potential effec-
tive  anti-inﬂammatory doses (Table 3). It is possible that
these  doses (2 and 4 mg/kg—Table 5) have reached the
maximum anti-inﬂammatory effect, since the attempt of
the  formalin test was primarily to examine the analgesic
effect. Therefore, testing lower doses are warranted and
further  studies are needed to examine and expand this
novel  effect of propofol. This anti-inﬂammatory response
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f propofol also supports the widely accepted notion that
he  drug exerts a wide-range of non-anesthetic actions at
sually  sub-anesthetic doses that could be useful therapeu-
ically  (for review see reference 13). To further support this
otion,  propofol at doses of 0.5 and 1 mg/kg, i.p. reduced
he  general locomotor activity of the chicks in the open-
eld  activity paradigm (Table 3). These doses represent
bout 1/10–1/40 of the hypnotic doses of the drug. The
ecreases in open-ﬁeld activities (delayed or absence of
ovement, decreased ambulation and jumping attempts)
ogether with increased duration of tonic immobility- a
ear  related response further suggest the CNS depressant
ction of propofol at sub-anesthetic doses. Propofol at seda-
ive/anesthetic doses (10, 20, 40 and 80 mg/kg) in Japanese
uails delayed initiation of ambulation in the open-ﬁeld
est [47]. Such an effect would be expected because of
he  high dosage of propofol used. However, sedatives and
nesthetics at sub-hypnotic doses were reported to exert
entral  depressant actions, as found in the present study,
n  open-ﬁeld locomotor activity and tonic immobility in
hicks  [31,32,35,48–50].
Physostigmine was attempted to be used in the present
tudy to antagonize propofol-induced sleep in chicks, since
t  was reported to reverse propofol anesthesia in humans
22]. Further, preanesthetic administration of physostig-
ine increased the anesthetic dose of propofol in humans
21].  Physostigmine at 0.05, 0.1 and 0.2 mg/kg effectively
educed the duration of propofol sleep in the chicks by
3,  56 and 83%, respectively (Table 7). However, our ﬁnd-
ngs  indicate that caution should be practiced when using
hysostigmine in the avian species as lethality occurred
t  0.1 and 0.2 mg/kg dose groups of physostigmine. This
s  apparently a phenomenon of drug interaction between
hysostigmine and propofol and its reason is not clear at
resent.
In  conclusion, using the chick model presented here, the
ata  suggest that propofol induces CNS depression in chicks
esulting  in sedation, analgesia, anti-inﬂammatory action
nd  anesthesia dose dependently with wide safety margins.
hysostigmine can be cautiously used to antagonize the
entral  depressant action of propofol. Further clinical stud-
es  are needed to explore potential propofol applications in
he  chicken.
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